Principal Scientist
Stoke Therapeutics
Bedford, Massachusetts
Yanyan Cui (Ph.D) works as Principal Scientist in DMPK/ClinPharm of Stoke Therapeutics to support TOX/Clinical studies in development new drugs from ASO. Beyound bioanalysis and PK/TK analysis, he wored on anti-drug-antibody (ADA) investigation in DMPK. A successful ADA method development will be shared in 2022 AAPS meeting.
Disclosure information not submitted.
Tuesday, October 18, 2022
3:15 PM – 3:30 PM ET